PACT premier TM HT-96 MD1-36 PACT premier is a ph, Anion, Cation crystallization trial devised to test ph within a PEG/Ion screen.
|
|
- Kimberly Johnson
- 5 years ago
- Views:
Transcription
1 PACT premier TM HT-96 MD1-36 PACT premier is a ph, Anin, Catin crystallizatin trial devised t test ph within a PEG/In screen. MD1-36 cntains 96 x 1 ml reagents in a deep-well blck. Features f PACT premier A mdern, cmprehensive PEG/in screen. This 96-well screen is really 3 screens in ne: 24-well ph/peg screen 24-well catin/peg screen 48-well anin/peg screen Ratinale fr a new PEG/In screen The first step in crystallizatin is ften t reach fr a cmmercially available sparse matrix kit, and hpe that ne f the cnditins prduces smething that lks harvestable, r ptimizable. If n bvius leads cme ut f the screen, it is hard t learn anything frm the negative (precipitate and clear) results. Traditinal PEG/In screens prvide a lgical test f seven catins and eleven anins using PEG 3350 as the precipitatin agent. Hwever, the user has n cntrl ver ph and hence cannt determine the effect f ne catin r anin ver anther. Fr this reasn the PEG/ION/pH (PACT) screen has been develped t systematically test the effect f ph, anins and catins, using PEG as the precipitant. This screen has been implemented very successfully at the Netherlands Cancer Institute (NKI), and at the Oxfrd Prtein Prductin Facility (OPPF). PACT premier ph/peg screen This cnsists f fur brad range buffer systems (1) versus PEG These buffers allw ne t scan the ph range frm 4 t 9, withut changing the chemistry f the system, s effectively islating the effect f ph frm the effect f the buffer that causes the change in ph. There are a few screens that try t test crystallizatin space in a mre ratinal manner fr example, the Clear Strategy Screen and The Slubility Tl Kit. Prtein crystals grwn successfully with PACT premier. 1
2 PACT premier Catin/PEG screen This is made up f six catins (all with chlride cunter ins) that are cmbined with PEG 6000 at fur different phs: Acetate ph 5, MES ph 6, HEPES ph 7 and Tris ph 8. The catins tested are Na +, NH 4 +, Li +, Mg 2+, Ca 2+ and Zn 2+. The zinc in is tested at lwer cncentratin than the ther catins in the screen (0.01 M vs. 0.2 M) Anin/PEG screen This is made up f 12 anins, with either sdium r ptassium cunter ins, which are tested at 0.2 M against PEG The anins include fluride, brmine, idide, thicyanate, nitrate, frmate, acetate, sulfate, tartrate, phsphate, citrate and malnate. The phsphate slutin is tested at a cncentratin f 0.02 M. Chlride is nt included here as it is the cunter in in the catin screen. Three sets f reagents are tested at ph 6.5, 7.5, and 8.5 with the Bis-Tris-Prpane buffer system whilst ne set f reagents is tested withut buffering. Frmulatin Ntes PACT premier reagents are frmulated using ultrapure water (>18.0 MΩ) and are sterile-filtered using 0.22 µm filters. N preservatives are added. Final ph may vary frm that specified n the datasheet. Mlecular Dimensins will be happy t discuss the precise frmulatin f individual reagents. Individual reagents and stck slutins fr ptimizatin are available frm Mlecular Dimensins. Enquiries regarding PACT-premier frmulatin, interpretatin f results r ptimizatin strategies are welcme. Please , fax r phne yur query t Mlecular Dimensins. Cntact and prduct details can be fund at References: (1)Newman et al (2005). Twards ratinalizatin f crystallizatin screening fr small- t medium-sized academic labratries: the PACT/JCSG+ strategy. Acta Cryst. D61, PACT premier- when used tgether with JCSG plus as a primary screening strategy is an extremely pwerful and successful cmbinatin, (i.e. a cmbinatin f a mdern sparse matrix apprach and an infrmatin yielding systematic trial). 2
3 PACT premier HT-96 Cnditins A1 D12 MD1-36 Well # Cnc. Salt Cnc. Buffer ph Cnc. Precipitant A1 0.1 M SPG % w/v PEG 1500 A2 0.1 M SPG % w/v PEG 1500 A3 0.1 M SPG % w/v PEG 1500 A4 0.1 M SPG % w/v PEG 1500 A5 0.1 M SPG % w/v PEG 1500 A6 0.1 M SPG % w/v PEG 1500 A7 0.2 M Sdium chlride 0.1 M Sdium acetate % w/v PEG 6000 A8 0.2 M Ammnium chlride 0.1 M Sdium acetate % w/v PEG 6000 A9 0.2 M Lithium chlride 0.1 M Sdium acetate % w/v PEG 6000 A M Magnesium chlride hexahydrate 0.1 M Sdium acetate % w/v PEG 6000 A M Calcium chlride dihydrate 0.1 M Sdium acetate % w/v PEG 6000 A M Zinc chlride 0.1 M Sdium acetate % w/v PEG 6000 B1 0.1 M MIB % w/v PEG 1500 B2 0.1 M MIB % w/v PEG 1500 B3 0.1 M MIB % w/v PEG 1500 B4 0.1 M MIB % w/v PEG 1500 B5 0.1 M MIB % w/v PEG 1500 B6 0.1 M MIB % w/v PEG 1500 B7 0.2 M Sdium chlride 0.1 M MES % w/v PEG 6000 B8 0.2 M Ammnium chlride 0.1 M MES % w/v PEG 6000 B9 0.2 M Lithium chlride 0.1 M MES % w/v PEG 6000 B M Magnesium chlride hexahydrate 0.1 M MES % w/v PEG 6000 B M Calcium chlride dihydrate 0.1 M MES % w/v PEG 6000 B M Zinc chlride 0.1 M MES % w/v PEG 6000 C1 0.1 M PCTP % w/v PEG 1500 C2 0.1 M PCTP % w/v PEG 1500 C3 0.1 M PCTP % w/v PEG 1500 C4 0.1 M PCTP % w/v PEG 1500 C5 0.1 M PCTP % w/v PEG 1500 C6 0.1 M PCTP % w/v PEG 1500 C7 0.2 M Sdium chlride 0.1 M HEPES % w/v PEG 6000 C8 0.2 M Ammnium chlride 0.1 M HEPES % w/v PEG 6000 C9 0.2 M Lithium chlride 0.1 M HEPES % w/v PEG 6000 C M Magnesium chlride hexahydrate 0.1 M HEPES % w/v PEG 6000 C M Calcium chlride hexahydrate 0.1 M HEPES % w/v PEG 6000 C M Zinc chlride 0.1 M HEPES % w/v PEG 6000 D1 0.1 M MMT % w/v PEG 1500 D2 0.1 M MMT % w/v PEG 1500 D3 0.1 M MMT % w/v PEG 1500 D4 0.1 M MMT % w/v PEG 1500 D5 0.1 M MMT % w/v PEG 1500 D6 0.1 M MMT % w/v PEG 1500 D7 0.2 M Sdium chlride 0.1 M Tris % w/v PEG 6000 D8 0.2 M Ammnium chlride 0.1 M Tris % w/v PEG 6000 D9 0.2 M Lithium chlride 0.1 M Tris % w/v PEG 6000 D M Magnesium chlride hexahydrate 0.1 M Tris % w/v PEG 6000 D M Calcium chlride dihydrate 0.1 M Tris % w/v PEG 6000 D M Zinc chlride 0.1 M Tris % w/v PEG
4 PACT premier HT-96 Cnditins E1 H12 MD1-36 Well # Cnc. Salt Cnc. Buffer ph Cnc. Precipitant E1 0.2 M Sdium fluride 20 % w/v PEG 3350 E2 0.2 M Sdium brmide 20 % w/v PEG 3350 E3 0.2 M Sdium idide 20 % w/v PEG 3350 E4 0.2 M Ptassium thicyanate 20 % w/v PEG 3350 E5 0.2 M Sdium nitrate 20 % w/v PEG 3350 E6 0.2 M Sdium frmate 20 % w/v PEG 3350 E7 0.2 M Sdium acetate trihydrate 20 % w/v PEG 3350 E8 0.2 M Sdium sulfate 20 % w/v PEG 3350 E9 0.2 M Ptassium sdium tartrate tetrahydrate 20 % w/v PEG 3350 E M Sdium/ptassium phsphate 20 % w/v PEG 3350 E M Sdium citrate tribasic dihydrate 20 % w/v PEG 3350 E M Sdium malnate dibasic mnhydrate 20 % w/v PEG 3350 F1 0.2 M Sdium fluride 0.1 M Bis-Tris prpane % w/v PEG 3350 F2 0.2 M Sdium brmide 0.1 M Bis-Tris prpane % w/v PEG 3350 F3 0.2 M Sdium idide 0.1 M Bis-Tris prpane % w/v PEG 3350 F4 0.2 M Ptassium thicyanate 0.1 M Bis-Tris prpane % w/v PEG 3350 F5 0.2 M Sdium nitrate 0.1 M Bis-Tris prpane % w/v PEG 3350 F6 0.2 M Sdium frmate 0.1 M Bis-Tris prpane % w/v PEG 3350 F7 0.2 M Sdium acetate trihydrate 0.1 M Bis-Tris prpane % w/v PEG 3350 F8 0.2 M Sdium sulfate 0.1 M Bis-Tris prpane % w/v PEG 3350 F9 0.2 M Ptassium sdium tartrate tetrahydrate 0.1 M Bis-Tris prpane % w/v PEG 3350 F M Sdium/ptassium phsphate 0.1 M Bis-Tris prpane % w/v PEG 3350 F M Sdium citrate tribasic dihydrate 0.1 M Bis-Tris prpane % w/v PEG 3350 F M Sdium malnate dibasic mnhydrate 0.1 M Bis-Tris prpane % w/v PEG 3350 G1 0.2 M Sdium fluride 0.1 M Bis-Tris prpane % w/v PEG 3350 G2 0.2 M Sdium brmide 0.1 M Bis-Tris prpane % w/v PEG 3350 G3 0.2 M Sdium idide 0.1 M Bis-Tris prpane % w/v PEG 3350 G4 0.2 M Ptassium thicyanate 0.1 M Bis-Tris prpane % w/v PEG 3350 G5 0.2 M Sdium nitrate 0.1 M Bis-Tris prpane % w/v PEG 3350 G6 0.2 M Sdium frmate 0.1 M Bis-Tris prpane % w/v PEG 3350 G7 0.2 M Sdium acetate trihydrate 0.1 M Bis-Tris prpane % w/v PEG 3350 G8 0.2 M Sdium sulfate 0.1 M Bis-Tris prpane % w/v PEG 3350 G9 0.2 M Ptassium sdium tartrate tetrahydrate 0.1 M Bis-Tris prpane % w/v PEG 3350 G M Sdium/ptassium phsphate 0.1 M Bis-Tris prpane % w/v PEG 3350 G M Sdium citrate tribasic dihydrate 0.1 M Bis-Tris prpane % w/v PEG 3350 G M Sdium malnate dibasic mnhydrate 0.1 M Bis-Tris prpane % w/v PEG 3350 H1 0.2 M Sdium fluride 0.1 M Bis-Tris prpane % w/v PEG 3350 H2 0.2 M Sdium brmide 0.1 M Bis-Tris prpane % w/v PEG 3350 H3 0.2 M Sdium idide 0.1 M Bis-Tris prpane % w/v PEG 3350 H4 0.2 M Ptassium thicyanate 0.1 M Bis-Tris prpane % w/v PEG 3350 H5 0.2 M Sdium nitrate 0.1 M Bis-Tris prpane % w/v PEG 3350 H6 0.2 M Sdium frmate 0.1 M Bis-Tris prpane % w/v PEG 3350 H7 0.2 M Sdium acetate trihydrate 0.1 M Bis-Tris prpane % w/v PEG 3350 H8 0.2 M Sdium sulfate 0.1 M Bis-Tris prpane % w/v PEG 3350 H9 0.2 M Ptassium sdium tartrate tetrahydrate 0.1 M Bis-Tris prpane % w/v PEG 3350 H M Sdium/ptassium phsphate 0.1 M Bis-Tris prpane % w/v PEG 3350 H M Sdium citrate tribasic dihydrate 0.1 M Bis-Tris prpane % w/v PEG 3350 H M Sdium malnate dibasic mnhydrate 0.1 M Bis-Tris prpane % w/v PEG
5 Abbreviatins: HEPES; N-(2-hydrxyethyl)-piperazine-N'-2-ethanesulfnic acid, MES; 2-(N-mrphlin)ethanesulfnic acid, PEG; Plyethylene glycl, Tris; 2-Amin-2-(hydrxymethyl)prpane-1,3-dil, SPG buffer; Succinic Acid, Phsphate, Glycine, MIB buffer; Malnic acid, Imidazle, Bric acid, PCTP buffer; Prpinic acid, Cacdylate, Bis-tris prpane, MMT buffer; Malic acid, MES, Tris. Manufacturer s safety data sheets are available frm ur website r by scanning the QR cde here: Ordering details: Catalgue Descriptin Catalgue Cde PACT premier (96 x 10 ml kit) MD1-29 PACT premier HT-96 (96 x 1 ml) MD1-36 PACT premier Ec Screen (96 x 10 ml kit) MD1-29-ECO PACT premier HT-96 Ec Screen (96 x 1 ml) MD1-36-ECO Green Screens PACT premier Green Screens (96 x 10 ml kit) MD1-55 PACT premier HT-96 Green Screens (96 x 1 ml) MD1-52 Single Reagents PACT premier (100 ml) MDSR-29 - tube number PACT premier HT-96 (100 ml) MDSR-36 - well number PACT premier Green screen (100 ml) MDSR-55 - tube number PACT premier Green screen HT-96 (100 ml) MDSR-52 - well number Fr PACT premier stck reagents visit ur Optimizatin page n ur website. 5
PACT premier,* HT-96 MD1-36. PACT premier is a ph, Anion, Cation crystallization trial devised to test ph within a PEG/Ion screen environment.
PACT premier,* HT-96 MD1-36 PACT premier is a ph, Anion, Cation crystallization trial devised to test ph within a PEG/Ion screen environment. The HT kit contains 96 1ml reagents in a deep-well block arranged
More informationmoleculardimensions.com
PACT premier TM HT-96 Green Screen MD1-52 PACT premier is a ph, Anion, Cation crystallization trial devised to test ph within a PEG/Ion screen environment with fluorescent dye added for superb UV performance.
More informationThe Stura Footprint Combination HT-96 MD1-43 Rapidly analyse the crystallization potential of your protein and protein complexes.
The Stura Footprint Combination HT-96 MD1-43 Rapidly analyse the crystallization potential of your protein and protein complexes. The footprint screens are based on the concept of screening the protein
More informationMD1-38 is presented as a 96 x 10 ml condition targeted sparse matrix screen.
ProPlex MD1-38 ProPlex is formulated for the crystallization of Protein complexes. Developed and tested by Sergei Radaev et al, at the NIH National Institute of Allergy and Infectious Diseases. MD1-38
More informationMemGold TM. MD1-39 is presented as 96 x 10 ml conditions.
MemGold TM MD1-39 MemGold* is based on crystallization conditions data mined from the Protein Data Bank and is a rationalized sparse matrix screen containing 96 conditions covering a range of ph, PEGs
More informationMultiXtal Formulation
MultiXtal HT-96 MD1-66 A great addition to any crystallization lab - a 48 condition sparse matrix Hi-PEG crystallization screen offering multiple uses for crystallization. For soluble and membrane proteins.
More informationStructure Screen 1 & 2 HT-96 Eco Screen
Structure Screen 1 & 2 HT-96 Eco Screen MD1-30-ECO Structure Screen 1 & 2 HT-96 Eco Screen is a 96 reagent, sparse-matrix screen of Structure Screen 1, and the classic extension to this screen, Structure
More informationMD1-64-GREEN is a targeted sparse matrix presented as a 96 x 1 ml deep-well block.
MemGold2 HT-96 Green Screen MD1-64-GREEN MemGold2 - The latest innovation for crystallization of membrane proteins. This screen targets all alpha helical types of Prokaryotic and Eukaryotic membrane proteins
More informationTypical ph conditions used for membrane protein crystallization. Total concentration of salts used for membrane protein crystallization.
MemStart MD1-21 A starting point for screening and optimizing crystallization conditions for α-helical type transmembrane proteins. A targeted sparse matrix of 48 conditions (10 ml) allowing the ph range,
More informationMD1-74-ECO. MemGold Eco Screen Combo Value Pack (MD1-39-ECO & MD1-63-ECO)
MD1-74-ECO MemGold Eco Screen Combo Value Pack (MD1-39-ECO & MD1-63-ECO) 1 MemGold TM Eco Screen MD1-39-ECO MemGold* is based on crystallization conditions data mined from the Protein Data Bank and is
More informationMembrane Proteins. MemGoldMeso 10 ml and HT-96* MD1-114, MD1-115
MemGoldMeso 10 ml and HT-96* MD1-114, MD1-115 MemGoldMeso is rational sparse-matrix screen based on a hand-curated database of in meso phase crystallization conditions data-mined from the Protein Data
More informationClear Strategy TM Screen I HT-96 A 6 4 matrix screen 1 that offers a more rational, logical and flexible approach to crystallization experiments.
Clear Strategy TM Screen I HT-96 MD1-31 A 6 4 matrix screen 1 that offers a more rational, logical and flexible approach to crystallization experiments. MD1-31 is presented as a 96 x 1 ml conditions in
More informationMD1-05. The Stura Footprint Combination (MD1-20 & MD1-22)
MD1-05 The Stura Footprint Combination (MD1-20 & MD1-22) The Stura Footprint Screen MD1-20 Rapidly analyse the crystallization potential of your protein and protein complexes. The footprint screens are
More informationMD1-32 is presented as 96 x 1 ml conditions in a deep-well block.
Clear Strategy TM Screen II HT-96 MD1-32 A complimentary screen 1 to CSS-I, with flexible scaffolding of parameters, easily modified to the specific needs of a project. Easily interpret results and optimize
More informationMemMeso TM MD1-86. MemMeso TM A 96-condition crystallization screen specifically for use with mesophases. (LCP compatible). Features of MemMeso:
MemMeso TM MD1-86 MemMeso TM A 96-condition crystallization screen specifically for use with mesophases. (LCP compatible). MD1-86 is a targeted sparse matrix presented as a 96 x 10 ml conditions. Features
More informationMIDASplus MD MD1-106 is presented as 96 x 10 ml conditions.
MIDASplus MD1 106 MIDASplus : The original MIDAS screen with new precipitants explore chemical space even further with this new and improved crystallization kit. MD1-106 is presented as 96 x 10 ml conditions.
More informationMD1-60 is presented as 96 x 1 ml conditions in a deep-well block.
MIDAS TM HT-96 MD1 60 MIDAS TM : a Modern Intelligent Dynamic Alternative Screen - A revolutionary 96 condition crystallization screen based on alternative polymeric precipitants 1. MD1-60 is presented
More informationThe original systematic screen for membrane proteins.
MemSys MD1-25 The original systematic screen for membrane proteins. 48 conditions allowing the ph range, precipitants and salts used in membrane protein crystallization to be screened with detergent containing
More informationThe PGA Screen TM HT-96. The kit contains 96 1ml conditions in a deep-well block.
The PGA Screen TM HT-96 MD1-51 A novel precipitant and a totally new crystallization space to explore. A revolutionary new systematic screen from the York Structural Biology Laboratory (YSBL) based on
More informationCryoProtX MD1 61. MD1-61 is presented as a 46 x 1.5 ml kit. To be used in conjunction with the Quick-Start Guide. Features of CryoProtX :
CryoProtX MD1 61 Get better results from your crystals This kit is designed for the cryoprotection of protein crystals and is for use after the crystals have been grown. Get the most out of your protein
More informationCryoProtX TM Eco Screen
CryoProtX TM Eco Screen MD1 61-ECO Get better results from your crystals Preserve the highest diffraction potential of your crystals with this easy-to-use pre-mixed cryo-kit. MD1-61-ECO is presented as
More informationModule 1: Overview of soil fertility, plant nutrition, and nutrient management. To view the chapter for this topic click here.
Mdule 1: Overview f sil fertility, plant nutritin, and nutrient management T view the chapter fr this tpic click here. Mdule 1: Overview Intrductin Understanding the principles f sil fertility is vital
More informationComparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity
Supporting information Volume 72 (2016) Supporting information for article: Comparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity Gwen E. Owens, Danielle M. New, Alejandra
More informationMembrane and Soluble Proteins
Morpheus 10 ml, HT-96 and FX-96 pre-filled plate MD1 46, MD1-47 and MD1-47-FX Morpheus is a 96 condition 3D protein crystallization screen incorporating a range of low-molecular weight ligands. Unlock
More informationVITAPRO. Detoxification properties of Apple pectin formulation, PROPECTIN. CENTRE D ETUDE ET DE VALORISATION DES ALGUES FINAL REPORT.
CENTRE D ETUDE & DE VALORISATION DES ALGUES 2400 Detxificatin prperties f Apple pectin frmulatin, PROPECTIN. VITAPRO FINAL REPORT PrPectin July 2015 CENTRE D ETUDE ET DE VALORISATION DES ALGUES PRESQU
More informationEURL-SRM - Analytical Observations Report
cncerning the fllwing EURL-SRM - Analytical Observatins Reprt Cmpund(s): Pymetrzine Cmmdities: Varius cmmdities f plant rigin Methd(s): QuEChERS, adjustment f ph Instrumentatin: LC-MS/MS Analysis f Pymetrzine
More informationMD1-46 is presented as 96 x 10 ml conditions.
Morpheus MD1 46 A 96 condition 1 3D protein crystallization screen incorporating a range of lowmolecular weight ligands. Unlock novel chemical space previously inaccessible using conventional screens.
More informationChapter 17 Acids and Bases (same as Exam 2 Worksheet Answers)
xam 3 Wrksheet Answers xam 3 Wrksheet Answers Chemistry 4 Chapter 17 Acids and Bases (same as xam Wrksheet Answers) 1. Fr the weak acids, what is the pk a and rank the acids accrding t strength? 4.74 6.38;.3
More informationRUBIC Additive Screen MD1-97 For stable, happy proteins From purification all the way through to characterization by NMR, SAXS or Crystallography.
RUBIC Additive Screen MD1-97 For stable, happy proteins From purification all the way through to characterization by NMR, SAXS or Crystallography. RUBIC Additive Screen- Screen a wide-range of small molecules
More informationUser Guide HR2-451 (pg 1)
Solutions for Crystal Growth User Guide HR2-451 (pg 1) Applications GRAS reagent crystallization screen for proteins, including monoclonal antibodies, where low molecular weight Polyethylene glycol is
More informationBIOLOGY 101. CHAPTER 7: Membrane Structure and Function: Life at the Edge
BIOLOGY 101 CHAPTER 7: Membrane Structure and Functin: Life at the Edge Membrane Structure and Functin: Life at the Edge CONCEPTS: 7.1 Cellular membranes are fluid msaics f lipids and prteins 7.2 Membrane
More informationMonensin and Extruded Urea-Grain for Range Beef Cows
Mnensin and Extruded Urea-Grain fr Range Beef Cws R. P. Lemenager, F. N. Owens, w. E. Sharp, Merwin Cmptn and Rbert Ttusek Stry in Brief Tw trials were cnducted t evaluate the supplemental value f mnensin
More informationPROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon
PROTOCOL Cmplex II Enzyme Activity Micrplate Assay Kit 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 MS241 Rev.0 DESCRIPTION Cmplex II Enzyme Activity Micrplate Assay Kit Sufficient materials are prvided
More informationFDA Dietary Supplement cgmp
FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes
More informationMETHOD 8032 ACRYLAMIDE BY GAS CHROMATOGRAPHY
METHOD 8032 ACRYLAMIDE BY GAS CHROMATOGRAPHY 1.0 SCOPE AND APPLICATION 1.1 Methd 8032 is used t determine trace amunts f acrylamide mnmer in aqueus matrices. This methd may be applicable t ther matrices.
More informationDATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS
DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this
More informationHow to Get Set Up and Running with NDepend
Hw t Get Set Up and Running with NDepend Whether yu have purchased r dwnladed the trial f NDepend, we thank yu fr yur invlvement and interest in ur prduct. Here we have cmpiled a quick "Getting Started"
More informationAction plan: serialisation of Nordic packages focus on Product Codes
19.6.2017, versin 5 Actin plan: serialisatin f Nrdic packages fcus n Prduct Cdes The aim f this dcument is t help pharma cmpanies t prepare fr prduct cde changes and t be able t maintain prduct cdes in
More informationSolaire Medical Electronic Lock Software
Slaire Medical Electrnic Lck Sftware The electrnic lck sftware Mdifies lck settings Pair sftware with lck type (keypad, prx lck, keypad with prx lck) and reset aut-lck time Manages emplyee prfile database
More informationCnsideratin fr Optimizatin: Optimizatin is a prgram transfrmatin technique, which tries t imprve the cde by making it cnsume fewer resurces (i.e. CPU, Memry) and deliver high speed. In ptimizatin, high-level
More informationPain relief after surgery
Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read
More informationMD1-76. Power Combo Value Pack (MD1-46 & MD1-59)
MD1-76 Power Combo Value Pack (MD1-46 & MD1-59) Morpheus MD1 46 A 96 condition, 3D protein crystallization screen incorporating a range of lowmolecular weight ligands. Unlock novel chemical space previously
More informationCSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009
CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral
More informationSugar Rush: The Science of Sweet
Sugar Rush: The Science f Sweet FRAMEWORK I. Scientific and Engineering Practices II. Crss-Cutting Cncepts III. Physical Sciences SKILLS/OBJECTIVES T bserve the results f hands-n experiments and make inferences/draw
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationFood information to consumers - Commission proposal - COM (2008) 40 final 2008/0028 (COD) The European Heart Network s position in a nutshell
Fd infrmatin t cnsumers - Cmmissin prpsal - COM (2008) 40 final 2008/0028 (COD) The Eurpean Heart Netwrk s psitin in a nutshell Summary On 30 January 2008 the Eurpean Cmmissin published its prpsal fr a
More informationMD1-46 is presented as 96 x 10 ml conditions.
Morpheus MD1 46 A 96 condition 1 3D protein crystallization screen incorporating a range of lowmolecular weight ligands. Unlock novel chemical space previously inaccessible using conventional screens.
More informationAssessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams
Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.
More informationThe Mental Capacity Act 2005; a short guide for the carers and relatives of those who may need support. Ian Burgess MCA Lead 13 February 2017
The Mental Capacity Act 2005; a shrt guide fr the carers and relatives f thse wh may need supprt Ian Burgess MCA Lead 13 February 2017 Agenda Overview f the MCA The 5 Principles and the legal definitin
More informationFUNCTIONAL MOVEMENT SYSTEMS SCREEN FINDINGS REPORT
FUNCTIONA MOVEMENT SYSTEMS SCEEN FINDINGS EPOT Screening Date: Client: FMS Certified Member: FMS Scre: 09/0/1 04:15 PM Glenn D'Avanz Elizabeth Carus 17 Descriptin: FMS screen fr Glenn D'Avanz FUNCTIONA
More informationThe Cannabis Act and Regulations
The and Regulatins OVERVIEW The and Regulatins cme int frce n Octber 17, 2018 and replaces the Access t Cannabis fr Medical Purpses Regulatins (ACMPR), and any mentin f Cannabis and Marihuana in the Narctics
More informationPILI Lifestyle Program Facilitator s Guide
Update: Octber 13, 2006 Page 1 f 12 PILI Lifestyle Prgram Facilitatr s Guide Sessin 3: Lwering Fat & Getting a Mve n Questin/Tpic Script Reminder/Activity Page Welcme back! Alha and welcme t the third
More informationMGPR Training Courses Guide
MGPR Training Curses Guide fiscal cde 92107050921 1. Descriptin The training prgram supprted by MGPR is prpsed by a grup f excellent mentrs/educatrs, accmplished in Pesticides Management and Analysis,
More informationManufacturer of High Purity Chemicals PRODUCT LIST
Manufacturer of High Purity Chemicals PRODUCT LIST Ammonium NH4 Ammonium Jost Chemical Co. manufactures a range of high purity ammonium phosphates, sulfates and citrates. Ammonium phosphates can be used
More informationPATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to:
PATIENT INFORMATION Rsuvastatin Calcium (re-soo-va-stat-in KAL-see-um) Tablets Read this Patient Infrmatin carefully befre yu start taking rsuvastatin calcium tablets and each time yu get a refill. If
More information1100 Marie Mount Hall College Park, Maryland Tel: (301) Fax: (301)
UNIVERSITY SENATE 1100 Marie Munt Hall Cllege Park, Maryland 20742-7541 Tel: (301) 405-5805 Fax: (301) 405-5749 http://www.senate.umd.edu March 31, 2017 Jrdan Gdman Chair, University Senate 2208G Physical
More informationThe easy way to smart lighting
Lighting The easy way t smart lighting LED InstantFit Lamps with Technlgy Philips InstantFit lamp with technlgy means easy upgrade t smart lighting system withut re-wiring the fixtures. 2.4GHz mesh netwrking
More informationUnderstanding Blood Counts
Understanding Bld Cunts PMH This pamphlet is fr patients at Princess Margaret Hspital. It will help yu t read and understand the bld cunt infrmatin yu get frm the bld lab. Patient Educatin Imprving Health
More informationPercutaneous Nephrolithotomy (PCNL)
Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this
More informationPodcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10
Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family
More informationHealth Consumers Queensland submission
Health Cnsumers Queensland submissin Inquiry int Public Health (Medicinal Cannabis) Bill 2016 Queensland Parliament Health, Cmmunities, Disability Services and Family Vilence Preventin Cmmittee Cntact:
More informationCancer Association of South Africa (CANSA)
Cancer Assciatin f Suth Africa (CANSA) Fact Sheet and Psitin Statement n Cannabis in Suth Africa Intrductin Cannabis is a drug that cmes frm Indian hemp plants such as Cannabis sativa and Cannabis indica.
More informationSESSION HANDOUTS ANXIETY SYMPTOMS INTERVENTION. Assertiveness Checklist and Stepladders Fighting Fear by Facing Fear Form SESSION
SESSION ANXIETY SYMPTOMS INTERVENTION SESSION HANDOUTS 9 Handut 9.1: Handut 9.2: Handut 9.3: Handut 9.4: Why Be a Cnfident Persn? Becming Assertive Assertiveness Checklist and Stepladders Fighting Fear
More informationReference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57
Reference: Patient A Brenda WXXXXX Date f Birth: 4/15/57 49 year ld white female patient presented n July 20, 2006 with chief cmplaint f stage 4 cancer, initially diagnsed in Octber, 2003 with Cervical
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationTABLE OF CONTENTS Glossary of terms Code Pad Diagram 3. Understanding the Code Pad lights.4.
TABLE OF CONTENTS... Glssary f terms 2... Cde Pad Diagram 3 Understanding the Cde Pad lights.4 Cde Pad tnes 5 Fully arming the system - ON MODE 6 Fully arming the system - Quick Arm MODE 6 Partially arming
More informationHumanities and Social Sciences Division. o Work Experience, General. o Open Entry/Exit. Distance (Hybrid Online) for online supported courses
SECTION A - Curse Infrmatin 1. Curse ID: 2. Curse Title: 3. Divisin: 4. Department: 5. Subject: 6. Shrt Curse Title: 7. Effective Term:: SIGN 108 Fingerspelling Humanities and Scial Sciences Divisin Sign
More informationLower Extremity Amputation (LEA) Considerations / Issues
Lwer Extremity Amputatin (LEA) Cnsideratins / Issues Prviding Te Fillers can be an advantageus resurce fr yur patient and business but it als cmes with certain cnsideratins. Please review this list belw
More informationCrystal Screens. JBScreen Family JBScreen Formulations. Crystallography
Crystal Screens JBScreen Family JBScreen Formulations ACCCACGAAAGGGAA ATAAGC AACO TTCAGGGAAGAA CTAUAACTGCCAC ACCCACGAAAGGGAA ATAAGC AACO TTCAGGGAAGAA CTAUAACTGCCAC ACCCACGAAAGGGAA ATAAGC AACO TTCAGGGAAGAA
More informationWALNUT KERNEL-HALVES (light color)
WALNUT KERNEL-HALVES (light clr) DESCRIPTION Prduct: rganic walnut kernels, separate int tw parts apprximately equal and intact, light clred T be cnsidered "half", 7/8 r mre f the kernel must be intact
More informationGlaucoma Interviews: Due Tuesday, May 22 nd
Glaucma Interviews: Due Tuesday, May 22 nd 1) Read the glaucma article well! It will explain what it is, plus tell yu sme symptms and risk factrs. Yu may want t use a highlighter r pen t mark imprtant
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationTechnology to overcome challanges
Technlgy t vercme challanges MORE THAN 25 YEARS DEVELOPING SOLUTIONS Przyn is a cmpany specialized in enzymes slutins and biingredients applicatins, ver 25 years f experience in develping bitechnlgy slutins.
More informationABIOpure TM Total RNA (version 2.0)
ABIOpure TM Ttal RNA (versin 2.0) Bld Extractin Handbk Cat N: M541RP50-B FOR RESEARCH USE ONLY Table f Cntents Cntents Page Kit Cmpnents 3 Precautins 3 Stability & Strage 4 General Descriptin 4 Limitatins
More informationOHlympia: becoming the PRODIGY. A Special Thanks to Cary K for giving me the opportunity to do this!
OHlympia: becming the PRODIGY A Special Thanks t Cary K fr giving me the pprtunity t d this! Prdigy defined by Webster is a nun described as a persn f unusual talent r marvelus talents, r anything that
More informationDesigning successful membrane protein crystallisation screens: how we designed MemGold. Simon Newstead
Designing successful membrane protein crystallisation screens: how we designed MemGold Simon Newstead Barriers to structure X-ray diffraction is currently the most successful method Requires good crystals
More informationEXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION
EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION The Bitechnlgy Innvatin Organizatin (BIO) and ur member
More informationPackage leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium
Package leaflet: Infrmatin fr the user Fragmin Graduated Syringe 10,000 IU/ml Slutin fr Injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains
More informationCall for evidence on the use of skin sensitisers, skin irritants and corrosive substances in textile and leather articles, hides and furs
Call fr evidence n the use f skin sensitisers, skin irritants and crrsive substances in textile and leather articles, hides and furs Backgrund dcument Backgrund Prductin and prcessing f textile and leather
More informationFinding the right 90 people in 90 days and what to do with them:
Finding the right 90 peple in 90 days and what t d with them: Wh can yu give the 3 packets (with instructins) t? Current Preferred Custmers nt currently n the Daily Essentials Packets. Friends and Family
More informationInitial Postoperative Knee Care Patella or Quadriceps Tendon Repairs: - Videos are available on Dr. Witty s website: drjeffreywitty.
Initial Pstperative Knee Care Patella r Quadriceps Tendn Repairs: - Vides are available n Dr. Witty s website: drjeffreywitty.cm Imprtant Phne Numbers: - Please see the cntact infrmatin abve fr imprtant
More informationMEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) tablets
MEDICATION GUIDE XARELTO (zah-rel-te) (rivarxaban) tablets Read this Medicatin Guide befre yu start taking XARELTO and each time yu get a refill. There may be new infrmatin. This Medicatin Guide des nt
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More informationThe Cell Cycle & Cellular Division
The Cell Cycle & Cellular Divisin Name: Perid: Date: I. Cell Divisin: All are derived frm preexisting cells (Cell Thery) is the prcess by which cells prduce new cells Cells grw in number, NOT in Smaller
More informationTest 3 Study Guide: Photosynthesis, Respiration, and the Cell Membrane
Name Blck Date Test 3 Study Guide: Phtsynthesis, Respiratin, and the Cell Membrane Test Dates: December 13 (1 st and 7 th blck) and 12 (6 th blck) SOL: BIO.2d, 3d-e Related Ntes Phtsynthesis Respiratin
More informationINTRODUCTION TO THE CIRCULATORY SYSTEM
INTRODUCTION TO THE CIRCULATORY SYSTEM What des bld d? 5. What makes this pssible? : In rder fr there t be an efficient exchange f xygen, waste and nutrients there must be a high surface area between the
More informationPROTOCOL. SOD2 Protein Quantity Microplate Assay Kit. MS746 Rev.0 DESCRIPTION INTRODUCTION
PROTOCOL SOD2 Prtein Quantity Micrplate Assay Kit 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 MS746 Rev.0 DESCRIPTION SOD2 Prtein Quantity Micrplate Assay Kit Sufficient materials are prvided fr
More informationDosage Administration
Pharmacy Technician Dsage Administratin Dsage Administratin Dsage Frms and Their Usages Medicatins ften cnsist f small quantities f active ingredients cmbined with inactive ingredients t create varius
More informationYou may have a higher risk of bleeding if you take warfarin sodium tablets and:
MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain
More informationEffects of Lyophilization on the Catalytic Properties of Extracellular Fructosyltransferase from Rhodotorula sp. LEB-V10
Internatinal Research Jurnal f Bitechnlgy (ISSN: 2141-5153) Vl. 3(6) pp. 96-111, June 2012 Available nline http://www.interesjurnals.rg/irjob Cpyright 2012 Internatinal Research Jurnals Full Length Research
More informationOEE Studio Release Note
OEE Studi Release Nte Versin 3.2 Deb-Tech Systems, Inc. & Prductin Imprvement Systems Ltd. Debbie.Olk@DebTechSystems.cm Russell@PrductinImprvement.cm 847.854.3148 What s New in 3.2 IMPROVED SPEED due t
More informationMitosis and Meiosis Lecture Notes
Bilgy Mitsis and Meisis Lecture Ntes Name Per Learning Gals Quiz #6: December 6th Describe what happens during interphase Identify steps f mitsis/meisis by picture and functin Explain the diseases that
More informationOntario s Approach to Federal Cannabis Legalization
Ontari s Apprach t Federal Cannabis Legalizatin Ontari s Key Areas f Fcus Ontari s regulatry apprach will align with the federal gvernment s legislative framewrk (see Appendix fr further detail n federal
More informationInstruction Manual IC ACCESS CONTROL
Instructin Manual IC ACCESS CONTROL Mde: DH16A-12CT Metal surface and keypads Un-netwrked Mde: DH16A-12CTQ Metal surface and keypads Netwrked Mde: DH16A-50CT/CTN Metal surface and keypads Un-netwrked Mde:
More information( ) ( ) + ( ) ( ) ( ) + ( )
xam 4 Wrksheet Answers xam 4 Wrksheet Answers Chemistry 104 Chapter 19 lectrchemistry (19.1 19.3 repeated frm xam 3 wrksheet) 1. What is the xidatin state f each element? 0 0 d. 0 e. f. g. 0. What is the
More informationREGISTERED REPORTS AUTHOR AND REVIEWER GUIDELINES
REGISTERED REPORTS AUTHOR AND REVIEWER GUIDELINES A Registered Reprt is a frm f empirical article ffered at Nature Human Behaviur in which the methds and prpsed analyses are pre-registered and reviewed
More informationCorporate Governance Code for Funds: What Will it Mean?
Crprate Gvernance Cde fr Funds: What Will it Mean? The Irish Funds Industry Assciatin has circulated a draft Vluntary Crprate Gvernance Cde fr the Funds Industry in Ireland. 1. Backgrund On 13 June 2011,
More informationCONSUMER MEDICINE INFORMATION
CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers sme cmmn questins abut CEFTRIAXONE lcp. It des nt cntain all the available infrmatin. It des nt take the place f talking t yur
More information